ArticleFrontiers in pharmacology2019

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism.

Xin Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.